# Progress Note 05 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Joe Frazier (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX004-SYN-TD
- Date: 2008-07-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Clarence Whitfield, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic adult preventive visit. **S**

## History of present illness

Mr. Frazier is a 64-year-old former professional heavyweight boxer who runs a boxing gym, with type 2 diabetes, hypertension, hyperlipidemia, obesity, and compensated cirrhosis from MASLD found this spring, who comes for his yearly preventive visit eight weeks after his three-month review. He takes semaglutide 1 mg weekly, metformin, lisinopril, amlodipine 10 mg and atorvastatin without missed doses. His home blood pressure readings average 126/78. He has lost 5.4 kg since intake and has had no alcohol since the liver results. He had the dilated eye examination three weeks ago after missing the first appointment. He asked again whether the blows he took in the ring will affect his memory; today's cognitive screen was done for that reason. He has no new symptoms. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 64 |
| Diabetes | A1c 7.3% at three months; semaglutide 1 mg weekly |
| Blood pressure | Home average 126/78 |
| Liver | Compensated cirrhosis from MASLD; next surveillance ultrasound and AFP in September |
| Mood and memory | PHQ-2 1; MoCA 26 today |

## Health risk assessment

Completed by the patient with the medical assistant reading the questions aloud, because he reads with one eye, and reviewed with him by Dr. Whitfield. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, and better since the spring |
| Psychosocial | Busy and proud of his fighters; money is tight; has people he can rely on |
| Substance use | No alcohol since the spring; never used tobacco |
| Physical activity | On his feet at the gym most days; walks after dinner |
| Nutrition | Smaller portions on semaglutide; less fried food and salt |
| Sleep | Seven hours; snores at times; no witnessed pauses in breathing; not sleepy in the day |
| Hearing | No difficulty in conversation |
| Vision | Reads with his right eye; left eye poor for years |
| Falls and safety | No falls; keeps the gym floor clear; wears a seat belt |
| Activities of daily living | Independent |
| Memory | No trouble with appointments, money or medicines; he worries about the future |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever; weight down by design |
| Eyes | Negative | No new change in vision |
| Ears, nose, mouth, and throat | Negative | No hearing loss or gum bleeding |
| Cardiovascular | Negative | No chest pain, palpitations or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No black stools, vomiting of blood, abdominal swelling or yellowing; mild nausea in the first weeks of each semaglutide step, now gone |
| Genitourinary | Negative | No trouble passing urine; gets up once at night |
| Musculoskeletal | Positive | Aching knees after long days; no joint swelling |
| Integumentary | Negative | No foot sores |
| Neurological | Negative | No headaches, tremor, numbness or unsteadiness |
| Psychiatric | Negative | Mood good; PHQ-2 1; no confusion, irritability or change in personality noticed by him or reported to him |

11 systems reviewed. **S**

## Current medications

- Metformin 1000 mg oral tablet, one tablet twice daily with meals; taken for years **S**
- Lisinopril 20 mg oral tablet, one tablet daily; taken for years **S**
- Atorvastatin 40 mg oral tablet, one tablet daily **S**
- Amlodipine 10 mg oral tablet, one tablet daily **S**
- Semaglutide pen (1 mg per dose), 1 mg under the skin once weekly **S**

## Allergies

- No known allergy **S**

## Objective

BP 124/76 mmHg; pulse 72 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 98.6 kg; BMI 29.8 kg/m². All vital signs are synthetic.

PHQ-2: 1; MoCA: 26. All results are synthetic.

## Immunizations given today

- Recombinant zoster vaccine, dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 98.6 kg, BMI 29.8; blood pressure 124/76; pulse 72 |
| Eyes | Right eye 20/30; left eye counting fingers at 1 meter, unchanged |
| Ears | Whispered-voice test normal on both sides |
| Cardiovascular | Regular rhythm; no murmur; no ankle edema |
| Respiratory | Clear to auscultation |
| Abdomen | Soft; spleen tip not felt; no ascites; no tenderness |
| Skin | No jaundice, spider angiomas or foot sores |
| Neurological | Alert and fluent; no tremor or asterixis; gait steady; normal finger-to-nose and rapid alternating movements |
| Psychiatric | Good-humored and engaged |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated. Colorectal cancer screening is due; he chose PSA screening after a discussion of benefits and harms. Montreal Cognitive Assessment 26 of 30, within the normal range, with no difficulty in daily function. Chronic traumatic encephalopathy cannot be diagnosed during life, so no such label is given; the plan is to protect brain health and repeat the screen in a year or sooner if he or those around him notice changes. **S**
   - Colonoscopy ordered.
   - PSA drawn today.
   - Next preventive visit in one year with a repeat MoCA.
2. **Compensated cirrhosis from MASLD** (K74.69). No sign of decompensation. Six-month surveillance ultrasound and AFP due in September. **S**
   - Liver ultrasound with AFP at the seven-month visit.
   - No alcohol; no NSAIDs.
3. **Type 2 diabetes** (E11.65). Improving; eye examination done three weeks ago, with no diabetic retinopathy in the right eye and no retinopathy seen in the left. **S**
   - A1c at the seven-month visit.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 124/76 mmHg; home average 126/78 |
| Colorectal cancer screening | Ordered | Last colonoscopy more than ten years ago and normal; colonoscopy ordered, with anesthesia aware of his cirrhosis |
| Prostate cancer screening | Ordered | Shared decision for men 55 to 69, discussing his higher risk as a Black man; he chose a PSA test, drawn today |
| Lung cancer screening | Not indicated | Never smoked |
| Hepatitis C, hepatitis B and HIV screening | Up to date | Nonreactive at intake; vaccinated against hepatitis B |
| Depression screening | Completed today | PHQ-2 1 |
| Unhealthy alcohol use | Up to date | AUDIT-C 2 at intake; no alcohol since the liver diagnosis |
| Cognitive screening | Completed today | MoCA 26, within the normal range; asked for by him because of his career |
| Diabetic eye examination | Up to date | Dilated examination three weeks ago; next in one year |
| Diabetic foot examination | Up to date | At intake; next in one year |
| Statin therapy | Up to date | Atorvastatin 40 mg; LDL 68 mg/dL |
| Liver cancer surveillance | Due | Ultrasound with AFP every six months; next in September |
| Recombinant zoster vaccine | Completed today | Dose 1 today; dose 2 in two to six months |
| Pneumococcal vaccine | Up to date | PCV20 in March |
| Hepatitis A and B vaccines | Due | Hepatitis B series complete; hepatitis A dose 2 in September |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap at intake |
| Influenza, COVID-19 and RSV vaccines | Due | At the September visit; RSV vaccine recommended because of his age, diabetes and chronic liver disease |
| Aspirin for primary prevention | Not indicated | Bleeding risk with cirrhosis outweighs benefit |

## Advance care planning

Voluntary advance care planning discussion of about 18 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is staying independent and keeping his gym open for the young fighters. He chose not to record specific treatment preferences today and would like to talk again after his next liver checks. The plan will be revisited yearly or after any serious illness. **S**

## Guideline basis

- AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma (2023), American Association for the Study of Liver Diseases (Hepatology 2023;78(6))
- National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome (2021), Neurology 2021;96(18)
- Adult Immunization Schedule by Medical Condition and Other Indication (2026), Centers for Disease Control and Prevention
- CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension and hyperlipidemia monographs (2026), Aether Forge
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force

## Follow-up

- Seven-month review in nine weeks with the surveillance ultrasound and AFP, A1c, kidney tests, the second zoster dose and the autumn vaccines. PSA result by phone. Colonoscopy to be scheduled. Next preventive visit in one year. **S**
- Next scheduled visit 2008-09-14: seven-month review: six-month liver cancer surveillance ultrasound and AFP, A1c, kidney function, urine albumin and vaccines. **S**
